Exicure XCUR
NASDAQ XCUR
$1.16 +0.04 (+3.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Exicure (XCUR) Other Accumulated Expenses (2025 - 2026)

Updated

Exicure (XCUR) reported Other Accumulated Expenses of $33,000 for Q2 2026.

Analysis

Exicure (XCUR) Other Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025, Exicure posted Other Accumulated Expenses of $299,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Exicure 7.39 Mn 7.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33,000.00
Dec 31, 2025 299,000.00
API Access

Exicure Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=XCUR&period=max&api_key=YOUR_API_KEY